PFE vs REGN
Pfizer, Inc. Common Stock · Regeneron Pharmaceuticals, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | PFE | REGN |
|---|---|---|
| Price | $29.39 | $904.35 |
| Market Cap | $167.51B | $85.38B |
| P/E | 21.56 | 18.95 |
| P/B | 1.97 | 2.55 |
| P/S | 2.68 | 5.95 |
| ROE | 9.1% | 13.4% |
| Net Margin | 12.4% | 31.4% |
| Gross Margin | — | — |
| Revenue Growth | -1.6% | 1.0% |
| Dividend Yield | 5.85% | — |
| EPS | $1.36 | $47.72 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.